• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Lupin Ltd.
    29 Sep 2025, 11:14AM
    Acquisition
    1911.30
    -1.13%
    Lupin Acquires VISUfarma To Expand European Ophthalmology Market Presence
    Lupin Acquires VISUfarma To Expand European Ophthalmology Market Presence
    NDTV Profit
    VISUfarma B.V. is headquartered in Amsterdam and it is a specialty pharmaceutical company focused on ophthalmology.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
    Lupin subsidiary Nanomi BV inks pact to acquire Netherlands-based VISUfarma
    Business Standard | 29 Sep 2025, 10:15AM 1 more
    Lupin subsidiary inks pact to acquire Netherlands-based VISUfarma
    Business Line | 29 Sep 2025, 10:08AM
    logo
    Sun Pharmaceutical Industries Ltd.
    29 Sep 2025, 10:56AM
    1594.30
    0.31%
    Trump Tariffs: Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure
    Trump Tariffs: Bitter Pill For Sun Pharma? Goldman Sachs Explains Why The Drugmaker May Face Pressure
    NDTV Profit
    Goldman Sachs has said the move won't have too much of an impact on Indian pharma companies, as a majority of them rely on generics as the main revenue stream.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 1351 to 1326 in Jun 2025 qtr
    US Tariffs: Only Sun Pharma Exposed To Some Headline Risk, But With Limited Earnings Impact
    NDTV Profit | 28 Sep 2025 2 more
    Sun Pharma hit by US tariff risk, but earnings impact to remain limited
    Business Standard | 28 Sep 2025
    Sun Pharma stares at 8-10% profit risk amid 100% Trump tariffs, says HSBC. Can the giant navigate this?
    Economic Times | 28 Sep 2025
    logo
    Wockhardt Ltd.
    29 Sep 2025, 10:23AM
    1516.00
    -3.09%
    Wockhardt Rebounds From Friday's Slump; Stock Surges 9% Here's Why
    Wockhardt Rebounds From Friday's Slump; Stock Surges 9% Here's Why
    NDTV Profit
    Wockhardt Pharma was one of the worst hit pharma stocks in India following Trump's announcement, falling more than 9% in two trading sessions.
    Copy LinkShare onShare on Share on Share on
    Wockhardt Ltd. average weekly volume is high.
    logo
    Glenmark Pharmaceuticals Ltd.
    28 Sep 2025
    Dividend
    1952.70
    -0.28%
    Glenmark Pharmaceuticals To Trade Ex-Dividend This Week
    Glenmark Pharmaceuticals To Trade Ex-Dividend This Week
    NDTV Profit
    To be eligible for dividends, investors should take note of the record date, which determines shareholder eligibility.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 404 to 396 in Jun 2025 qtr
    Corporate Actions This Week: Glenmark Pharma, Star Housing Finance, Paushak And More
    NDTV Profit | 28 Sep 2025
    logo
    Laurus Labs Ltd.
    26 Sep 2025
    841.80
    0.10%
    Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs
    Laurus Labs Downplays Impact Of New US Pharma Tariffs On Branded Drugs
    NDTV Profit
    Lauras Labs derives 40% of its revenue from antiretroviral (ARV) drugs, which remain insulated from US tariffs.
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. is trading below its 30 day SMA of 884.1
    logo
    Sun Pharmaceutical Industries Ltd.
    26 Sep 2025
    1594.30
    0.31%
    Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception
    Trump Tariffs May Not Hurt Indian Companies, Says Morgan Stanley: THIS Pharma Stock An Exception
    NDTV Profit
    Morgan Stanley believes the impact could be limited, as far as the Indian market is concerned. However, companies like Sun Pharma could be at risk due to their speciality drug presence in the US.
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading below all available SMAs
    Trump Slaps 100% Pharma Tariffs: What It Means For Indian Companies
    NDTV Profit | 26 Sep 2025
    logo
    Sun Pharmaceutical Industries Ltd.
    26 Sep 2025
    1594.30
    0.31%
    Sun Pharma hits 52-week low as pharma giants navigate US tariff threat
    Business Line
    The stock has seen heavy selling pressure with over 52 lakh shares traded, declining 2.96 per cent to 1,579.20, generating turnover of 827.93 crore by 12.50 pm
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical I.. has an average target of 2050.25 from 8 brokers.
    logo
    Piramal Pharma Ltd.
    25 Sep 2025
    191.16
    -0.25%
    Broker's call: Piramal Pharma (Add)
    Business Line
    InCred Equities
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors decreased from 257 to 247 in Jun 2025 qtr
    logo
    Alembic Pharmaceuticals Ltd.
    25 Sep 2025
    Insider Trades
    901.35
    0.86%
    Alembic Pharma Gets USFDA Nod For Generic Drug To Treat Depression, Anxiety
    Alembic Pharma Gets USFDA Nod For Generic Drug To Treat Depression, Anxiety
    NDTV Profit
    The final approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) of Paroxetine extended-release tablets of strengths 25 mg and 37.5 mg, Alembic Pharmaceuticals said in a regulatory filing.
    Copy LinkShare onShare on Share on Share on
    Alembic Pharmaceuticals Ltd. is trading below all available SMAs
    logo
    Glenmark Pharmaceuticals Ltd.
    25 Sep 2025
    Dividend
    1952.70
    -0.28%
    Why Nomura continues to back Glenmark Pharma; Retains 'Buy'; Find out here
    Business Standard
    Analysts at Nomura continue to back Glenmark Pharma, citing the company's ability to strategically acquire high-potential innovative products.
    Copy LinkShare onShare on Share on Share on
    Glenmark Pharmaceuticals Ltd. is trading below its 30 day SMA of 2012.3
    Glenmark Pharma secures global license for Hengrui's cancer drug
    Business Line | 24 Sep 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Rukmani Devi Garg Agro Impex
    • Om Freight Forwarders
    • Om Metallogic
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd (RA SEBI Reg No: INH000022507)